Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The goal of the study is to evaluate the safety and tolerability of 4 different doses of
iCo-007 Intravitreal Injection in patients with diffuse diabetic macular edema.